Published on May 13, 2019 - 3 min read
Head and neck cancers are one of the top three cancers worldwide. Radiation therapy has proved itself to be a valuable component of management of these cancers, either as an adjunct to surgery, or alone depending upon various factors. There are multiple studies and trials in literature which has proven the equivalence of radiation therapy to surgery with lesser side effects.
Cancers of the head and neck region are a heterogeneous group of tumors affecting different areas such as the oral cavity, pharynx (nasopharynx, oropharynx, and hypopharynx), larynx, paranasal sinuses, nasal cavity, thyroid gland, etc. Each of these tumors behaves differently with a varied prognosis requiring a multidisciplinary approach (team of surgical, radiation and medical oncologists) for optimal management.
Local management options include surgery and radiation therapy, used either alone or latter as an adjuvant modality. In the adjuvant setting, the goal of radiation therapy is to prevent local recurrence. Role of radiation therapy has increased tremendously in the past decade, with nearly 60 percent of head and neck cancers requiring radiation therapy. The basic principle of radiation therapy is the maximum dose to the tumor and minimum to the nearby healthy organs. This has been made possible with advances in technology.
Depending on the stage of cancer, different management options are available. Factors which help in decision making can be categorized as patient related (age, associated co-morbidities, performance status, finances), disease-related (site, histology, stage), and treatment-related (cost, side effects). Early stage disease can be managed using a single modality either surgery or radiation therapy. Locally advanced cases especially of the oral cavity, are usually treated with surgery followed by radiation therapy, where surgery removes the gross tumor and radiation therapy further sterilizes the tumor bed, thus minimizing the chances of recurrence. Further evidence has taught us that giving chemotherapy along with radiation therapy in select cases amplifies the effect of radiation, thus enhancing the chances of tumor control.
What Are the Indications for Radiation Therapy and Chemotherapy?
The general indications of radiation therapy in the postoperative setting are guided by principles of increased probability of local recurrence. These indications are:
Concurrent chemotherapy is indicated in a positive margin and extranodal extension. Each of these factors is associated with poor prognosis and requires aggressive combined modality approach.
Sites, where radiation with concurrent chemotherapy forms the definitive treatment and results are equivalent to surgery, are nasopharynx, oropharynx, hypopharynx, and larynx. The advantage of chemoradiation over surgery in these sites is function preservation. Other factors that may influence radiation over surgery are patient choice and morbidity associated with surgery higher than that associated with radiation.
Importance of Treating Nodal Involvement:
Another crucial aspect in the management of head and neck cancers that requires mentioning is the treatment of the nodes. Primary drainage nodes should always be the treatment, and proper knowledge of nodal drainage according to the site is very important. Recent studies have shown the importance of treating nodes prophylactically since survival is inversely related to nodal involvement.
What Are the Radiation-Related Side Effects?
Radiation-related side effects can be acute and/or delayed. Factors influencing these side effects can be categorized as patient related (age, associated co-morbidities, performance status), and treatment-related (radiation volume, dose to normal organs, the technique of radiation used, and concurrent chemotherapy). Acute complications are:
Complications experienced after six months:
What Are the Modern Advancement in Radiotherapy?
Modern radiotherapy techniques, such as intensity-modulated radiotherapy (IMRT) and image-guided radiotherapy (IGRT), can offer precise radiation delivery and reduce the dose to the surrounding normal tissues without compromising the target.
With these techniques, the intensity of radiation can be modulated so that a higher radiation dose can be delivered to the targets with a sharply conformal target volume coverage, while at the same time the dose to the surrounding normal tissues is markedly reduced.To give the best results, IGRT is usually combined with IMRT.
Query: Hi doctor,I have nose cancer, so I am going to get radiotherapy. The doctor said that the radiation might touch the eye, which may lead to loss of vision and eye removal. Is there any other way to prevent this? Please help. Read Full »
Query: Hello doctor, My mother is 55 years old. She was diagnosed with right breast carcinoma around 1.5 years back. She was treated with eight sessions of chemotherapy and then, surgery (mastectomy) and again, 25 sessions of radiation therapy. She got the last dose of radiation therapy around four months ... Read Full »
Query: Hi doctor, My mother, who is 55 years old, is undergoing chemotherapy for breast cancer T4 M1 (less than 5 mm non-avid in lymph node above lung) Nx, after mastectomy. She is HER2 positive and other two receptors are also positive. We have two different opinions in front of us from the two best onco... Read Full »
Do you have a question on Radiotherapy or Treatment Of Cancer?Ask a Doctor Online